Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Cefoselis hydrochloride exhibits good activity against a wide range of Gram-positive and Gram-negative organisms
Sodium phenylbutyrate is also a histone deacetylase inhibitor and chemical chaperone
OTS964 hydrochloride (intravenously
This selectivity profile
3800 and 6000 nM for MET
SU14813 maleate - CAS# 849643-15-8 Size:Solid 10 mg Cefoselis hydrochloride exhibits good activitySU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet derived growth factor receptors (PDGFR), KIT, and fms like tyrosine kinase 3 (FLT 3) (1). SU14813 was developed as a next generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity
US$ 241.00
US$ 132.00
US$ 126.50
US$ 135.50
US$ 275.00
US$ 52.00
US$ 1025.50
US$ 560.50
US$ 142.50
US$ 172.50
US$ 212.50